@Damoturbo12, may you have a favourable long-term prognosis.
It's hard to escape the feeling that we will experience success with our first in-human trial.
Recent SP action (for me) points to the likelihood of further patient recruitment and successful early results
in the trial/trials to date!
Of course, there is the possibility that things haven't gone to plan, however, the curious action from the
BoD to facilitate the expansion of new premises (Nov 2021-Jan 2022), the opening up of further recruiting sites
and the communications in terms of trial progressing with the original format to continue, I struggle to give
any credibility to the argument that things aren't going to plan.
Bottom line is that if all is going well with the trial (and I fully expect that it is) we are grossly undervalued;
It remains for us to guess I suppose until we receive official Co communication.
- Forums
- ASX - By Stock
- Price Prediction
@Damoturbo12, may you have a favourable long-term prognosis.It's...
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable